Mkts

Biodesix, Inc.

NASDAQ: BDSX
$23.25-1.47 (-5.93%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
22.7025.06
52-week range
5.2631.97
Today
Open25.06
Previous close23.25
Volume—
Valuation
Market cap245.37M
P/E ratio—
EPS (TTM)-3.17
Income & risk
Dividend / yield—
Beta0.61
Avg volume99.0K
Discussion

BDSX News

Stories mentioning BDSX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue25,55528,75521,76820,01817,95820,42918,15117,925
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development3,2852,8702,9923,2692,8702,4142,5472,558
Sales General & Admin24,26122,97221,71422,41120,44820,21920,01619,660
Total Operating Expenses31,75630,72228,81929,73727,09427,07826,74226,162
Operating Income (Loss)(6,201)(1,967)(7,051)(9,719)(9,136)(6,649)(8,591)(8,237)
Interest Income
Interest Expense1,9772,0592,0741,8981,6851,7532,0411,935
Other Expense385.00409.0051.0098.00374.00(387.00)
Pretax Income
Tax Provision0.000.00
Net Income (Loss)(7,793)(3,980)(8,716)(11,468)(11,101)(8,251)(10,258)(10,808)
Earnings Per Share (Basic)(0.81)(0.53)(1.16)(0.08)(1.52)(1.28)(1.40)(0.08)
Earnings Per Share (Diluted)(0.81)(0.53)(1.16)(0.08)(1.52)(1.28)(1.40)(0.08)
Weighted Average Shares Outstanding (Basic)9,6567,5517,500146,6567,3006,4707,315127,168
Weighted Average Shares Outstanding (Diluted)9,6567,5517,500146,6567,3006,4707,315127,168

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BDSX

Biodesix, Inc. (NASDAQ: BDSX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BDSX. It last traded at $23.25 (Oct 30, 2026, 4:00 PM ET), down 5.9% on the day. That gives Biodesix a market capitalisation of $245.4M.

Over the past 52 weeks BDSX has traded between $5.26 and $31.97.

Revenue for the quarter ended Mar 31, 2026 was $25.6M; a net loss of $7.8M. Revenue was up 42.3% from $18.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$25.6M-$7.8M-30.5%
Dec 31, 2025$28.8M-$4.0M-13.8%
Sep 30, 2025$21.8M-$8.7M-40.0%
Jun 30, 2025$20.0M-$11.5M-57.3%

From Biodesix’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…